Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 782

1.
2.

Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).

Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Carrasco JC, Requena MJ, Montironi R.

Eur Urol. 2004 May;45(5):606-12.

PMID:
15082203
3.

Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.

Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK.

Br J Cancer. 2001 Jan;84(2):270-5.

4.

Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.

Korkolopoulou P, Givalos N, Saetta A, Goudopoulou A, Gakiopoulou H, Thymara I, Thomas-Tsagli E, Patsouris E.

Hum Pathol. 2005 Aug;36(8):899-907.

PMID:
16112007
5.

Cyclin D3 expression in primary Ta/T1 bladder cancer.

Lopez-Beltran A, Requena MJ, Luque RJ, Alvarez-Kindelan J, Quintero A, Blanca AM, Rodriguez ME, Siendones E, Montironi R.

J Pathol. 2006 May;209(1):106-13.

PMID:
16482499
6.

Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.

Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P.

Hum Pathol. 2000 Jun;31(6):751-60.

PMID:
10872671
7.

Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer. Finbladder Group.

Liukkonen T, Lipponen P, Raitanen M, Kaasinen E, Ala-Opas M, Rajala P, Kosma VM.

Urol Res. 2000 Oct;28(5):285-92.

PMID:
11127704
8.

Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.

Mhawech P, Greloz V, Oppikofer C, Szalay-Quinodoz I, Herrmann F.

Cancer. 2004 Jun 1;100(11):2367-75.

10.

Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.

Kamai T, Takagi K, Asami H, Ito Y, Oshima H, Yoshida KI.

Br J Cancer. 2001 May 4;84(9):1242-51. Erratum in: Br J Cancer 2001 Aug 3;85(3):471.

11.

Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.

Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Taniguchi N, Monden M.

Hepatology. 1999 Jul;30(1):90-9.

PMID:
10385644
12.

Loss of p21Waf1 expression is a strong predictor of reduced survival in primary superficial bladder cancers.

Migaldi M, Sgambato A, Garagnani L, Ardito R, Ferrari P, De Gaetani C, Cittadini A, Trentini GP.

Clin Cancer Res. 2000 Aug;6(8):3131-8.

13.

Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder.

Santos LL, Amaro T, Pereira SA, Lameiras CR, Lopes P, Bento MJ, Oliveira J, Criado B, Lopes CS.

Eur J Surg Oncol. 2003 Feb;29(1):74-80.

PMID:
12559081
14.

Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.

Moonen L, Ong F, Gallee M, Verheij M, Horenblas S, Hart AA, Bartelink H.

Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1305-10.

PMID:
11286838
15.

Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder.

Khan AA, Abel PD, Chaudhary KS, Gulzar Z, Stamp GW, Lalani EN.

Mol Pathol. 2003 Dec;56(6):353-61.

16.
17.
18.

Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.

Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.

Anticancer Res. 2002 Nov-Dec;22(6B):3759-64.

PMID:
12552989
19.

Supplemental Content

Support Center